Drug Database
Back to search

United States· US:43598-308_1df6ec0d-0508-29af-33c2-3a9d19a040df

Plerixafor

A plerixafor product containing plerixafor, registered in United States by Dr. Reddy's Laboratories Inc. The same ATC class is registered in 17 of our 19 countries.

ATC L03AX16US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedPlerixaforATCL03AX16REGISTER NO.US:43598-308_1df6ec0d…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about plerixaforAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Plerixafor is registered in 17 of 19 countries.

Countries holding a registration under ATC L03AX16 (plerixafor), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 9 of them publish a price we can compare per daily dose
Search plerixafor products by name

Plerixafor · ATC L03AX16

17 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
PLERIXAFOR
Manufacturer
Dr. Reddy's Laboratories Inc
Country
United States (US)
ATC code
L03AX16
ATC class
Plerixafor
Defined daily dose
16.8 mg, P
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    4359830823
    1 VIAL, SINGLE-DOSE in 1 CARTON (43598-308-23) / 1.2 mL in 1 VIAL, SINGLE-DOSE
  • ndc11
    43598-308-23

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Plerixafor in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All plerixafor products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Plerixafor Stada, Plerixafor Teva
  • Bulgaria · Plerixafor Msn
  • Czechia · Pleforbil, Plerixafor Msn
  • Germany · Plerixafor Amarox, Plerixafor Puren
  • Denmark · Plerixafor Seacross, Plerixafor Teva
  • Estonia · Plerixafor Auxilia
  • Spain · Plerixafor Eugia, Plerixafor Glenmark
  • Finland · Plerixafor Seacross, Plerixafor Viatris
  • France · Plerixafor Arrow, Plérixafor Eg
  • United Kingdom (Northern Ireland) · Plerixafor Amarox Limited, Plerixafor Eugia (Uk)
  • Croatia · Pleriksafor Msn, Pleriksafor Onkogen
  • Hungary · Plerixafor Msn, Plerixafor Onkogen
  • Ireland · Plerixafor Msn Labs Europe, Plerixafor Seacross
  • Iceland · Mozobil, Plerixafor Accord
  • Italy · Plerixafor Aurobindo, Plerixafor Eg
  • Liechtenstein · Mozobil, Plerixafor Accord
  • Lithuania · Plerixafor Auxilia
  • Netherlands · Plerixafor Amarox, Plerixafor Sandoz
  • Norway · Mozobil, Plerixafor Accord
  • Poland · Plerixafor Biofar, Plerixafor Msn
  • Portugal · Plerixafor Eugia, Plerixafor Mylan
  • Romania · Plerixafor Msn Labs Europe
  • Sweden · Plerixafor Seacross, Plerixafor Teva
  • Slovenia · Pleriksafor Onkogen, Pleriksafor Teva
  • Slovakia · Plerixafor Msn, Plerixafor Onkogen

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b80e2227-f768-4d51-9fa8-3b9a27ba7ed5
GET /v1/drugs/b80e2227-f768-4d51-9fa8-3b9a27ba7ed5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "SUBCUTANEOUS",
  "source": "ndc",
  "strength": "24",
  "substance": "PLERIXAFOR",
  "productndc": "43598-308",
  "dosage_form": "SOLUTION",
  "dea_schedule": null,
  "strength_unit": "mg/1.2mL",
  "application_number": "ANDA205182",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about plerixafor.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console